I don’t understand what you are saying here. I thought EMR want a high price to convert their notes at the change in control price. ERM currently have an average cost in hfr of circa $1. Why would they buy anymore at a lower price they want to maximise the price to convert there notes and recover losses on existing shares they hold.
Ann: LoI for Cooperation on Strategic Investment, page-76
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add HFR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
-0.020(7.14%) |
Mkt cap ! $101.9M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.0¢ | 25.5¢ | $127.1K | 474.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 17925 | 26.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.0¢ | 1800 | 1 |
View Market Depth
| Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
| HFR (ASX) Chart |